LeeGELorchSASheffler-CollinsSKronmanMPShahSS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 2010;126:204-213.
2.
KerenRLuanXLocalioR. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166:1155-1164.
3.
BradleyJSByingtonCLShahSS. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76.
4.
NewmanREHedicanEBHerigonJCWilliamsDDWilliamsARNewlandJG. Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Pediatrics. 2012;129:e597-e604.
5.
QueenMAMyersALHallM. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia. Pediatrics. 2014;133:e23-e29.
6.
DedierJSingerDEChangYMooreMAtlasSJ. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med. 2001;161:2099-2104.
7.
NiedermanMSBassJBJrCampbellGD. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418-1426.
8.
AfsharNTabasJAfsharKSilbergleitR. Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review. J Hosp Med. 2009;4:112-123.
9.
ArboMDSnydmanDR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med. 1994;154:2641-2645.
10.
RamanujamPRathlevNK. Blood cultures do not change management in hospitalized patients with community-acquired pneumonia. Acad Emerg Med. 2006;13:740-745.
